ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹7,428 Cr | ₹6,851 Cr | ₹6,417 Cr | ₹4,899 Cr | ₹3,628 Cr |
What is the latest Net Current Assets ratio of ALKEM LABORATORIES ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹7,428 Cr |
| Mar2025 | ₹6,851 Cr |
| Mar2024 | ₹6,417 Cr |
| Mar2023 | ₹4,899 Cr |
| Mar2022 | ₹3,628 Cr |
How is Net Current Assets of ALKEM LABORATORIES Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹7,428 Cr | 8.43 | |
| Mar2025 | ₹6,851 Cr | 6.76 | |
| Mar2024 | ₹6,417 Cr | 30.98 | |
| Mar2023 | ₹4,899 Cr | 35.03 | |
| Mar2022 | ₹3,628 Cr | - | |
Compare Net Current Assets of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹64,344.8 Cr | -2.5% | -5.3% | 11.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,675.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,516.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,190.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹115,523.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,493.4 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | -2.5% |
-5.3% |
11.1% |
| SENSEX | -1% |
0.7% |
-3.6% |
You may also like the below Video Courses